Lipogems stem cell process helps heal Hungarian tiger始s joints



Igor, the Siberian tiger of Szeged Zoo, is being treated with a stem-cell procedure which has already proven its value in human medicine, and which - it is hoped - will relieve the joint pains the big cat has been suffering for many years, says a press release sent to the Budapest Business Journal.

The 13-year-old carnivore is being treated with a new process developed by Lipogems that has already been successfully used to treat human joints in Hungary. The process cures the injured joints with material taken from the patient鈥檚 own fatty tissue, which contains regenerative stem cells.

鈥淚gor鈥檚 hip joint will be treated like the hip joint of a human being. During the stem-cell joint treatment process, a small amount of fatty tissue is taken from the patient鈥檚 body, which after mechanical purification is implanted during a 45-60 minute procedure into the joint in need of treatment,鈥 said Dr. R贸bert Gippert, leading veterinarian at the Ro-Vet Small Animal Clinic in Kaposv谩r. 鈥淛ust like in humans, the worn-out joint of Igor the tiger will heal due to the regenerative and self-healing effects of stem cells, without the use of external materials,鈥 he added.

Every fifth person in the world suffers from the wear and tear of a large joint, be it the shoulder, hip, knee, ankle, elbow, or wrist, says the press release. Joint disorders affect not only people, but animals as well, including pets, horses, and exotic animals such as Igor.

The technology to improve the quality of life of patients suffering from joint disorders was developed in Italy in 2010. It offers 100% natural help to patients with joint problems, for those for whom other conservative treatments (painkillers or steroids)鈥 may no longer be of help, for whom the implantation of a prosthesis is not yet indicated or not possible, or where the patient is reluctant to accept the surgical procedure but their quality of life can only be sustained by the continuous use of painkillers.

鈥淎round 30,000 patients around the world and over 550 patients in Hungary have been treated so far with the Lipogems stem-cell joint treatment procedure,鈥 said J贸zsef Veres, managing director of Medropolitan Consulting Kft., the Hungarian business partner of the Lipogems process. 鈥淲e are confident that as in the case of human patients, Igor始s hip pain will soon be reduced dramatically or completely eliminated,鈥 he added.

Although the Lipogems procedure has been available in Hungary in human medicine for years, its veterinary application has only been explored recently. There are relatively few clinics that carry out this procedure, even in Western Europe and North America. In Central and Eastern Europe, it is currently available only in Hungary, where it has been used to treat horses, dogs, and now a tiger, noted the press release.


CIG Pann贸nia Board Proposes HUF 18-per-share Dividend Figures

CIG Pann贸nia Board Proposes HUF 18-per-share Dividend

Hungarian Lawmakers Ratify Finland's NATO Accession Parliament

Hungarian Lawmakers Ratify Finland's NATO Accession

IBS Reaches 50-50% Gender Ratio in Management HR

IBS Reaches 50-50% Gender Ratio in Management

S眉meg Castle Reopens History

S眉meg Castle Reopens


Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.